Articles

Enhancing Data Infrastructure in Manufacturing with Process Analytical Technologies (PAT) Securing product quality during manufacturing is essential for the safety and efficacy of the end bioproduct. Improved understanding of manufacturing processes can enhance transparency and ensure the production of high-quality...

The biopharmaceutical industry faces a future shaped by uncertainty in the wake of the pandemic-influenced world, yet overall growth is expected to continue. The Pharmaceutical Manufacturing Market Size Report states that the market will grow at a compound annual...

As 2023 takes over, there is a lot of hope that makes us cling to the pharmaceutical sector: a hope of getting novel ideas to work, a hope to embrace more technology, and a hope to fill the gap. To see...

Eric Hsu, Account Director of Alliance Management at Samsung Biologics, examines how we can apply the lessons of the COVID-19 pandemic to the biopharma industry in future. He also explores the ongoing trends in biologics manufacturing and the increased...

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter the market. Often presenting a more cost-effective alternative, biosimilars can provide greater access to...

For companies in the early stages of developing a new parenteral therapy, the focus within the product teams is naturally on the molecule and the science behind it. But when it’s time to transition that molecule from lab to...

Viral vectors play a vital role in the development of cell and gene therapies (C&GTs). By delivering genetic material to patients’ cells to replace dysfunctional or damaged DNA, these complex tools have helped to change patient outlook dramatically, particularly...